Industry Research Reports
Home > Reports > Service & Software > Global Cell Immortalization Market Outlook, In‑Depth Analysis & Forecast to 2032
Global Cell Immortalization Market Outlook, In‑Depth Analysis & Forecast to 2032
Industry: Service & Software
Published Date: 2026-04-30
Pages: 159 Pages
Report ld: 6699253
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Cell Immortalization Market Size(US$)
CAGR 2026-2032
5.9%
Market Size,2032
USD 5,461
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 3,863 million
Market Forecast in 2032(Value)
US$ 5,461 million
CAGR
5.9%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Cell Immortalization market is projected to grow from US$ 3642 million in 2025 to US$ 5461 million by 2032, at a CAGR of 5.9% (2026-2032), driven by critical product segments and diverse end‑use applications.
Cell immortalization refers to the biological process of enabling primary cells to exceed their inherent proliferative limits and gain unlimited division capacity through physical, chemical, or biological means. Normal somatic cells have a limited number of passages in vitro, while immortalization extends cell life and establishes stable cell lines by activating telomerase (e.g., hTERT gene transfection), inactivating tumor suppressor proteins (p53/Rb, such as HPV E6/E7 or SV40 large T antigen), or viral transformation (EBV). Immortalized cells can maintain their original differentiation characteristics and genotype for a long period and are widely used in fields such as tumor research, drug screening, vaccine production, and gene therapy. Representative immortalization technologies include telomerase overexpression, proto-oncogene induction, and spontaneous immortalization. This technology is one of the core tools for modern biomedical basic research and product development.
The global cell immortalization market and research are characterized by a pattern of technological leadership from Europe and the United States, and accelerated application and translation in the Asia-Pacific region. North America, as a leading birthplace, continues to innovate in CRISPR, iPSC reprogramming, and telomerase regulation technologies. Companies such as ATCC and Thermo Fisher provide standard immortalization kits and cell banks, widely used in target discovery and gene therapy. Europe has a deep foundation in tumor biology and mechanism research. ECACC and DSMZ have extremely high requirements for the traceability and ethical standards of immortalized cell lines, promoting the international circulation of high-quality cell resources. The Asia-Pacific region (China, Japan, and South Korea) is experiencing rapid growth in the development of novel immortalization vectors (lentiviruses, transposons) and the construction of industrialized cell lines, especially driven by CRO/CDMO and biosimilars, with strong demand for industrial-grade suspension-acclimated immortalized cell lines (such as HEK293 and CHO). Future trends include: conditional immortalization systems based on CRISPRa/i, non-transgenic transient immortalization technologies, and alternative methods that reduce the use of primary animals in accordance with the 3R principle. Obstacles: Immortification may alter the original cell phenotype; long-term passage leads to karyotype instability, and regulatory concerns about tumorigenicity increase the difficulty of review. Updates: FDA guidelines encourage the use of fully characterized immortalized cell lines to replace animal experiments; China's CDE has released guidelines for stable cell lines used in gene therapy products, and the industry is actively promoting animal-free immortalized reagents.
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Cell Immortalization market across value chain. It analyzes historical revenue data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players (revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middle stream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Lonza
- Thermo Fisher Scientific
- JSR
- Sartorius
- Merck
- AcceGen
- Creative Biolabs
- InSCREENex GmbH
- BioIVT
- Krishgen Biosystems
- Applied Biological Materials
- REPROCELL Inc
- FUJIFILM Wako Pure Chemical Corporation
- Abace Biotechnology
- CELLCOOK
- Procell
- Takara Bio
- Corning
- Evercyte
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Stem Cell Therapy
- Cell Transplantation
- Drug Transport
- Others
Segment by Application
- Pharmaceutical and Biopharmaceutical Company
- Research Laboratory
- Hospital
- Other
Segment by Category
- Human Cells
- Mouse Cells
- Non-mammal Cells
- Others
Segment by Division
- >30h
- 24-30h
- 18-24h
- <18h
CHAPTER OUTLINE
Chapter 1: Defines the Cell Immortalization study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape: ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down market size by Application and country, profiles key players and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional market by Application and players, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies market size by Application, and region/country, profiles top players, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures market size by Application, and country, profiles top players, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates market size by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth: details product specs, revenue, margins; top-tier players 2025 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments
Chapter 12: Value chain and ecosystem: analyses upstream, midstream, plus downstream channels
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Cell Immortalization: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Cell Immortalization Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Stem Cell Therapy
1.2.3 Cell Transplantation
1.2.4 Drug Transport
1.2.5 Others
1.3 Market Segmentation by Cell Types
1.3.1 Global Cell Immortalization Market Size by Cell Types, 2021 vs 2025 vs 2032
1.3.2 Human Cells
1.3.3 Mouse Cells
1.3.4 Non-mammal Cells
1.3.5 Others
1.4 Market Segmentation by Doubling Time
1.4.1 Global Cell Immortalization Market Size by Doubling Time, 2021 vs 2025 vs 2032
1.4.2 >30h
1.4.3 24-30h
1.4.4 18-24h
1.4.5 <18h
1.5 Market Segmentation by Application
1.5.1 Global Cell Immortalization Market Size by Application, 2021 vs 2025 vs 2032
1.5.2 Pharmaceutical and Biopharmaceutical Company
1.5.3 Research Laboratory
1.5.4 Hospital
1.5.5 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Cell Immortalization Revenue Estimates and Forecasts (2021-2032)
2.2 Global Cell Immortalization Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competitive Landscape
3.1 Global Cell Immortalization Players’ Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2021-2026)
3.1.2 Global Key Players’ Revenue Ranking (2024 vs 2025)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Players (2021 vs 2025)
3.2 Global Cell Immortalization Companies Headquarters and Service Footprint
3.3 Key Player Market Share by Product Type
3.3.1 Stem Cell Therapy: Market Share by Key Players
3.3.2 Cell Transplantation: Market Share by Key Players
3.3.3 Drug Transport: Market Share by Key Players
3.3.4 Others: Market Share by Key Players
3.4 Global Cell Immortalization Market Concentration and Dynamics
3.4.1 Global Market Concentration
3.4.2 Market Entry and Exit Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Product Segmentation
4.1 Global Cell Immortalization Market by Type
4.1.1 Global Revenue by Type (2021-2032)
4.1.2 Global Revenue-Based Market Share by Type (2021-2032)
4.2 Global Cell Immortalization Market by Cell Types
4.2.1 Global Revenue by Cell Types (2021-2032)
4.2.2 Global Revenue-Based Market Share by Cell Types (2021-2032)
4.3 Global Cell Immortalization Market by Doubling Time
4.3.1 Global Revenue by Doubling Time (2021-2032)
4.3.2 Global Revenue-Based Market Share by Doubling Time (2021-2032)
4.4 Key Product Attributes and Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Cell Immortalization Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.1.2 Revenue-Based Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2021-2032)
6.2 North America Key Players’ Revenue in 2025
6.3 North America Cell Immortalization Market Size by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Cell Immortalization Market Size by Country
6.5.1 North America Revenue Trends by Country
6.5.2 US
6.5.3 Canada
6.5.4 Mexico
7 Europe
7.1 Europe Market Size (2021-2032)
7.2 Europe Key Players’ Revenue in 2025
7.3 Europe Cell Immortalization Market Size by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Cell Immortalization Market Size by Country
7.5.1 Europe Revenue Trends by Country
7.5.2 Germany
7.5.3 France
7.5.4 U.K.
7.5.5 Italy
7.5.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2021-2032)
8.2 Asia-Pacific Key Players’ Revenue in 2025
8.3 Asia-Pacific Cell Immortalization Market Size by Application (2021-2032)
8.4 Asia-Pacific Growth Accelerators and Market Barriers
8.5 Asia-Pacific Cell Immortalization Market Size by Region
8.5.1 Asia-Pacific Revenue Trends by Region
8.6 China
8.7 Japan
8.8 South Korea
8.9 Australia
8.10 India
8.11 Southeast Asia
8.11.1 Indonesia
8.11.2 Vietnam
8.11.3 Malaysia
8.11.4 Philippines
8.11.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2021-2032)
9.2 Central and South America Key Players’ Revenue in 2025
9.3 Central and South America Cell Immortalization Market Size by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Cell Immortalization Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2021-2032)
10.2 Middle East and Africa Key Players’ Revenue in 2025
10.3 Middle East and Africa Cell Immortalization Market Size by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Cell Immortalization Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Israel
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 Lonza
11.1.1 Lonza Corporation Information
11.1.2 Lonza Business Overview
11.1.3 Lonza Cell Immortalization Product Features and Attributes
11.1.4 Lonza Cell Immortalization Revenue and Gross Margin (2021-2026)
11.1.5 Lonza Cell Immortalization Revenue by Product in 2025
11.1.6 Lonza Cell Immortalization Revenue by Application in 2025
11.1.7 Lonza Cell Immortalization Revenue by Geographic Area in 2025
11.1.8 Lonza Cell Immortalization SWOT Analysis
11.1.9 Lonza Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Corporation Information
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Cell Immortalization Product Features and Attributes
11.2.4 Thermo Fisher Scientific Cell Immortalization Revenue and Gross Margin (2021-2026)
11.2.5 Thermo Fisher Scientific Cell Immortalization Revenue by Product in 2025
11.2.6 Thermo Fisher Scientific Cell Immortalization Revenue by Application in 2025
11.2.7 Thermo Fisher Scientific Cell Immortalization Revenue by Geographic Area in 2025
11.2.8 Thermo Fisher Scientific Cell Immortalization SWOT Analysis
11.2.9 Thermo Fisher Scientific Recent Developments
11.3 JSR
11.3.1 JSR Corporation Information
11.3.2 JSR Business Overview
11.3.3 JSR Cell Immortalization Product Features and Attributes
11.3.4 JSR Cell Immortalization Revenue and Gross Margin (2021-2026)
11.3.5 JSR Cell Immortalization Revenue by Product in 2025
11.3.6 JSR Cell Immortalization Revenue by Application in 2025
11.3.7 JSR Cell Immortalization Revenue by Geographic Area in 2025
11.3.8 JSR Cell Immortalization SWOT Analysis
11.3.9 JSR Recent Developments
11.4 Sartorius
11.4.1 Sartorius Corporation Information
11.4.2 Sartorius Business Overview
11.4.3 Sartorius Cell Immortalization Product Features and Attributes
11.4.4 Sartorius Cell Immortalization Revenue and Gross Margin (2021-2026)
11.4.5 Sartorius Cell Immortalization Revenue by Product in 2025
11.4.6 Sartorius Cell Immortalization Revenue by Application in 2025
11.4.7 Sartorius Cell Immortalization Revenue by Geographic Area in 2025
11.4.8 Sartorius Cell Immortalization SWOT Analysis
11.4.9 Sartorius Recent Developments
11.5 Merck
11.5.1 Merck Corporation Information
11.5.2 Merck Business Overview
11.5.3 Merck Cell Immortalization Product Features and Attributes
11.5.4 Merck Cell Immortalization Revenue and Gross Margin (2021-2026)
11.5.5 Merck Cell Immortalization Revenue by Product in 2025
11.5.6 Merck Cell Immortalization Revenue by Application in 2025
11.5.7 Merck Cell Immortalization Revenue by Geographic Area in 2025
11.5.8 Merck Cell Immortalization SWOT Analysis
11.5.9 Merck Recent Developments
11.6 AcceGen
11.6.1 AcceGen Corporation Information
11.6.2 AcceGen Business Overview
11.6.3 AcceGen Cell Immortalization Product Features and Attributes
11.6.4 AcceGen Cell Immortalization Revenue and Gross Margin (2021-2026)
11.6.5 AcceGen Recent Developments
11.7 Creative Biolabs
11.7.1 Creative Biolabs Corporation Information
11.7.2 Creative Biolabs Business Overview
11.7.3 Creative Biolabs Cell Immortalization Product Features and Attributes
11.7.4 Creative Biolabs Cell Immortalization Revenue and Gross Margin (2021-2026)
11.7.5 Creative Biolabs Recent Developments
11.8 InSCREENex GmbH
11.8.1 InSCREENex GmbH Corporation Information
11.8.2 InSCREENex GmbH Business Overview
11.8.3 InSCREENex GmbH Cell Immortalization Product Features and Attributes
11.8.4 InSCREENex GmbH Cell Immortalization Revenue and Gross Margin (2021-2026)
11.8.5 InSCREENex GmbH Recent Developments
11.9 BioIVT
11.9.1 BioIVT Corporation Information
11.9.2 BioIVT Business Overview
11.9.3 BioIVT Cell Immortalization Product Features and Attributes
11.9.4 BioIVT Cell Immortalization Revenue and Gross Margin (2021-2026)
11.9.5 BioIVT Recent Developments
11.10 Krishgen Biosystems
11.10.1 Krishgen Biosystems Corporation Information
11.10.2 Krishgen Biosystems Business Overview
11.10.3 Krishgen Biosystems Cell Immortalization Product Features and Attributes
11.10.4 Krishgen Biosystems Cell Immortalization Revenue and Gross Margin (2021-2026)
11.10.5 Company Ten Recent Developments
11.11 Applied Biological Materials
11.11.1 Applied Biological Materials Corporation Information
11.11.2 Applied Biological Materials Business Overview
11.11.3 Applied Biological Materials Cell Immortalization Product Features and Attributes
11.11.4 Applied Biological Materials Cell Immortalization Revenue and Gross Margin (2021-2026)
11.11.5 Applied Biological Materials Recent Developments
11.12 REPROCELL Inc
11.12.1 REPROCELL Inc Corporation Information
11.12.2 REPROCELL Inc Business Overview
11.12.3 REPROCELL Inc Cell Immortalization Product Features and Attributes
11.12.4 REPROCELL Inc Cell Immortalization Revenue and Gross Margin (2021-2026)
11.12.5 REPROCELL Inc Recent Developments
11.13 FUJIFILM Wako Pure Chemical Corporation
11.13.1 FUJIFILM Wako Pure Chemical Corporation Corporation Information
11.13.2 FUJIFILM Wako Pure Chemical Corporation Business Overview
11.13.3 FUJIFILM Wako Pure Chemical Corporation Cell Immortalization Product Features and Attributes
11.13.4 FUJIFILM Wako Pure Chemical Corporation Cell Immortalization Revenue and Gross Margin (2021-2026)
11.13.5 FUJIFILM Wako Pure Chemical Corporation Recent Developments
11.14 Abace Biotechnology
11.14.1 Abace Biotechnology Corporation Information
11.14.2 Abace Biotechnology Business Overview
11.14.3 Abace Biotechnology Cell Immortalization Product Features and Attributes
11.14.4 Abace Biotechnology Cell Immortalization Revenue and Gross Margin (2021-2026)
11.14.5 Abace Biotechnology Recent Developments
11.15 CELLCOOK
11.15.1 CELLCOOK Corporation Information
11.15.2 CELLCOOK Business Overview
11.15.3 CELLCOOK Cell Immortalization Product Features and Attributes
11.15.4 CELLCOOK Cell Immortalization Revenue and Gross Margin (2021-2026)
11.15.5 CELLCOOK Recent Developments
11.16 Procell
11.16.1 Procell Corporation Information
11.16.2 Procell Business Overview
11.16.3 Procell Cell Immortalization Product Features and Attributes
11.16.4 Procell Cell Immortalization Revenue and Gross Margin (2021-2026)
11.16.5 Procell Recent Developments
11.17 Takara Bio
11.17.1 Takara Bio Corporation Information
11.17.2 Takara Bio Business Overview
11.17.3 Takara Bio Cell Immortalization Product Features and Attributes
11.17.4 Takara Bio Cell Immortalization Revenue and Gross Margin (2021-2026)
11.17.5 Takara Bio Recent Developments
11.18 Corning
11.18.1 Corning Corporation Information
11.18.2 Corning Business Overview
11.18.3 Corning Cell Immortalization Product Features and Attributes
11.18.4 Corning Cell Immortalization Revenue and Gross Margin (2021-2026)
11.18.5 Corning Recent Developments
11.19 Evercyte
11.19.1 Evercyte Corporation Information
11.19.2 Evercyte Business Overview
11.19.3 Evercyte Cell Immortalization Product Features and Attributes
11.19.4 Evercyte Cell Immortalization Revenue and Gross Margin (2021-2026)
11.19.5 Evercyte Recent Developments
12 Cell Immortalization Value Chain and Ecosystem Analysis
12.1 Cell Immortalization Value Chain (Ecosystem Structure)
12.2 Upstream Analysis
12.2.1 Key Technologies, Platforms and Infrastructure
12.3 Midstream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Cell Immortalization Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Cell Immortalization Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Cell Immortalization Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Cell Immortalization Market Size Growth Rate by Cell Types, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Cell Immortalization Market Size Growth Rate by Doubling Time, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Cell Immortalization Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Cell Immortalization Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Cell Immortalization Revenue by Region (US$ Million), 2021-2026
Table 7. Global Cell Immortalization Revenue by Region (US$ Million), 2027-2032
Table 8. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 9. Global Cell Immortalization Revenue by Players (US$ Million), 2021-2026
Table 10. Global Cell Immortalization Revenue-Based Market Share by Players (2021-2026)
Table 11. Global Key Players’Ranking Shift (2024 vs 2025) (Based on Revenue)
Table 12. Global Companies by Tier (Tier 1, Tier 2, and Tier 3), based on Cell Immortalization Revenue, 2025
Table 13. Global Cell Immortalization Average Gross Margin (%) by Player (2021 vs 2025)
Table 14. Global Cell Immortalization Companies Headquarters
Table 15. Global Cell Immortalization Market Concentration Ratio (CR5)
Table 16. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 17. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 18. Global Cell Immortalization Revenue by Type (US$ Million), 2021-2026
Table 19. Global Cell Immortalization Revenue by Type (US$ Million), 2027-2032
Table 20. Global Cell Immortalization Revenue by Cell Types (US$ Million), 2021-2026
Table 21. Global Cell Immortalization Revenue by Cell Types (US$ Million), 2027-2032
Table 22. Global Cell Immortalization Revenue by Doubling Time (US$ Million), 2021-2026
Table 23. Global Cell Immortalization Revenue by Doubling Time (US$ Million), 2027-2032
Table 24. Key Product Attributes and Differentiation
Table 25. Global Cell Immortalization Revenue by Application (US$ Million), 2021-2026
Table 26. Global Cell Immortalization Revenue by Application (US$ Million), 2027-2032
Table 27. Cell Immortalization High-Growth Sectors Demand CAGR (2026-2032)
Table 28. Top Customers by Region
Table 29. Top Customers by Application
Table 30. North America Cell Immortalization Growth Accelerators and Market Barriers
Table 31. North America Cell Immortalization Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 32. Europe Cell Immortalization Growth Accelerators and Market Barriers
Table 33. Europe Cell Immortalization Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 34. Asia-Pacific Cell Immortalization Growth Accelerators and Market Barriers
Table 35. Asia-Pacific Cell Immortalization Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Central and South America Cell Immortalization Investment Opportunities and Key Challenges
Table 37. Central and South America Cell Immortalization Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 38. Middle East and Africa Cell Immortalization Investment Opportunities and Key Challenges
Table 39. Middle East and Africa Cell Immortalization Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 40. Lonza Corporation Information
Table 41. Lonza Description and Major Businesses
Table 42. Lonza Product Features and Attributes
Table 43. Lonza Revenue (US$ Million) and Gross Margin (2021-2026)
Table 44. Lonza Revenue Proportion by Product in 2025
Table 45. Lonza Revenue Proportion by Application in 2025
Table 46. Lonza Revenue Proportion by Geographic Area in 2025
Table 47. Lonza Cell Immortalization SWOT Analysis
Table 48. Lonza Recent Developments
Table 49. Thermo Fisher Scientific Corporation Information
Table 50. Thermo Fisher Scientific Description and Major Businesses
Table 51. Thermo Fisher Scientific Product Features and Attributes
Table 52. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2021-2026)
Table 53. Thermo Fisher Scientific Revenue Proportion by Product in 2025
Table 54. Thermo Fisher Scientific Revenue Proportion by Application in 2025
Table 55. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2025
Table 56. Thermo Fisher Scientific Cell Immortalization SWOT Analysis
Table 57. Thermo Fisher Scientific Recent Developments
Table 58. JSR Corporation Information
Table 59. JSR Description and Major Businesses
Table 60. JSR Product Features and Attributes
Table 61. JSR Revenue (US$ Million) and Gross Margin (2021-2026)
Table 62. JSR Revenue Proportion by Product in 2025
Table 63. JSR Revenue Proportion by Application in 2025
Table 64. JSR Revenue Proportion by Geographic Area in 2025
Table 65. JSR Cell Immortalization SWOT Analysis
Table 66. JSR Recent Developments
Table 67. Sartorius Corporation Information
Table 68. Sartorius Description and Major Businesses
Table 69. Sartorius Product Features and Attributes
Table 70. Sartorius Revenue (US$ Million) and Gross Margin (2021-2026)
Table 71. Sartorius Revenue Proportion by Product in 2025
Table 72. Sartorius Revenue Proportion by Application in 2025
Table 73. Sartorius Revenue Proportion by Geographic Area in 2025
Table 74. Sartorius Cell Immortalization SWOT Analysis
Table 75. Sartorius Recent Developments
Table 76. Merck Corporation Information
Table 77. Merck Description and Major Businesses
Table 78. Merck Product Features and Attributes
Table 79. Merck Revenue (US$ Million) and Gross Margin (2021-2026)
Table 80. Merck Revenue Proportion by Product in 2025
Table 81. Merck Revenue Proportion by Application in 2025
Table 82. Merck Revenue Proportion by Geographic Area in 2025
Table 83. Merck Cell Immortalization SWOT Analysis
Table 84. Merck Recent Developments
Table 85. AcceGen Corporation Information
Table 86. AcceGen Description and Major Businesses
Table 87. AcceGen Product Features and Attributes
Table 88. AcceGen Revenue (US$ Million) and Gross Margin (2021-2026)
Table 89. AcceGen Recent Developments
Table 90. Creative Biolabs Corporation Information
Table 91. Creative Biolabs Description and Major Businesses
Table 92. Creative Biolabs Product Features and Attributes
Table 93. Creative Biolabs Revenue (US$ Million) and Gross Margin (2021-2026)
Table 94. Creative Biolabs Recent Developments
Table 95. InSCREENex GmbH Corporation Information
Table 96. InSCREENex GmbH Description and Major Businesses
Table 97. InSCREENex GmbH Product Features and Attributes
Table 98. InSCREENex GmbH Revenue (US$ Million) and Gross Margin (2021-2026)
Table 99. InSCREENex GmbH Recent Developments
Table 100. BioIVT Corporation Information
Table 101. BioIVT Description and Major Businesses
Table 102. BioIVT Product Features and Attributes
Table 103. BioIVT Revenue (US$ Million) and Gross Margin (2021-2026)
Table 104. BioIVT Recent Developments
Table 105. Krishgen Biosystems Corporation Information
Table 106. Krishgen Biosystems Description and Major Businesses
Table 107. Krishgen Biosystems Product Features and Attributes
Table 108. Krishgen Biosystems Revenue (US$ Million) and Gross Margin (2021-2026)
Table 109. Krishgen Biosystems Recent Developments
Table 110. Applied Biological Materials Corporation Information
Table 111. Applied Biological Materials Description and Major Businesses
Table 112. Applied Biological Materials Product Features and Attributes
Table 113. Applied Biological Materials Revenue (US$ Million) and Gross Margin (2021-2026)
Table 114. Applied Biological Materials Recent Developments
Table 115. REPROCELL Inc Corporation Information
Table 116. REPROCELL Inc Description and Major Businesses
Table 117. REPROCELL Inc Product Features and Attributes
Table 118. REPROCELL Inc Revenue (US$ Million) and Gross Margin (2021-2026)
Table 119. REPROCELL Inc Recent Developments
Table 120. FUJIFILM Wako Pure Chemical Corporation Corporation Information
Table 121. FUJIFILM Wako Pure Chemical Corporation Description and Major Businesses
Table 122. FUJIFILM Wako Pure Chemical Corporation Product Features and Attributes
Table 123. FUJIFILM Wako Pure Chemical Corporation Revenue (US$ Million) and Gross Margin (2021-2026)
Table 124. FUJIFILM Wako Pure Chemical Corporation Recent Developments
Table 125. Abace Biotechnology Corporation Information
Table 126. Abace Biotechnology Description and Major Businesses
Table 127. Abace Biotechnology Product Features and Attributes
Table 128. Abace Biotechnology Revenue (US$ Million) and Gross Margin (2021-2026)
Table 129. Abace Biotechnology Recent Developments
Table 130. CELLCOOK Corporation Information
Table 131. CELLCOOK Description and Major Businesses
Table 132. CELLCOOK Product Features and Attributes
Table 133. CELLCOOK Revenue (US$ Million) and Gross Margin (2021-2026)
Table 134. CELLCOOK Recent Developments
Table 135. Procell Corporation Information
Table 136. Procell Description and Major Businesses
Table 137. Procell Product Features and Attributes
Table 138. Procell Revenue (US$ Million) and Gross Margin (2021-2026)
Table 139. Procell Recent Developments
Table 140. Takara Bio Corporation Information
Table 141. Takara Bio Description and Major Businesses
Table 142. Takara Bio Product Features and Attributes
Table 143. Takara Bio Revenue (US$ Million) and Gross Margin (2021-2026)
Table 144. Takara Bio Recent Developments
Table 145. Corning Corporation Information
Table 146. Corning Description and Major Businesses
Table 147. Corning Product Features and Attributes
Table 148. Corning Revenue (US$ Million) and Gross Margin (2021-2026)
Table 149. Corning Recent Developments
Table 150. Evercyte Corporation Information
Table 151. Evercyte Description and Major Businesses
Table 152. Evercyte Product Features and Attributes
Table 153. Evercyte Revenue (US$ Million) and Gross Margin (2021-2026)
Table 154. Evercyte Recent Developments
Table 155. Technologies, Platforms and Infrastructure
Table 156. Distributors List
Table 157. Market Trends and Market Evolution
Table 158. Market Drivers and Opportunities
Table 159. Market Challenges, Risks, and Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell Immortalization Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 2. Stem Cell Therapy Product Picture
Figure 3. Cell Transplantation Product Picture
Figure 4. Drug Transport Product Picture
Figure 5. Others Product Picture
Figure 6. Global Cell Immortalization Market Size Growth Rate by Cell Types, 2021 vs 2025 vs 2032 (US$ Million)
Figure 7. Human Cells Product Picture
Figure 8. Mouse Cells Product Picture
Figure 9. Non-mammal Cells Product Picture
Figure 10. Others Product Picture
Figure 11. Global Cell Immortalization Market Size Growth Rate by Doubling Time, 2021 vs 2025 vs 2032 (US$ Million)
Figure 12. >30h Product Picture
Figure 13. 24-30h Product Picture
Figure 14. 18-24h Product Picture
Figure 15. <18h Product Picture
Figure 16. Global Cell Immortalization Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 17. Pharmaceutical and Biopharmaceutical Company
Figure 18. Research Laboratory
Figure 19. Hospital
Figure 20. Other
Figure 21. Cell Immortalization Report Years Considered
Figure 22. Global Cell Immortalization Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Cell Immortalization Revenue (US$ Million), 2021-2032
Figure 24. Global Cell Immortalization Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 25. Global Cell Immortalization Revenue-Based Market Share by Region (2021-2032)
Figure 26. Global Cell Immortalization Revenue-Based Market Share Ranking (2025)
Figure 27. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 28. Stem Cell Therapy Revenue-Based Market Share by Player in 2025
Figure 29. Cell Transplantation Revenue-Based Market Share by Player in 2025
Figure 30. Drug Transport Revenue-Based Market Share by Player in 2025
Figure 31. Others Revenue-Based Market Share by Player in 2025
Figure 32. Global Cell Immortalization Revenue-Based Market Share by Type (2021-2032)
Figure 33. Global Cell Immortalization Revenue-Based Market Share by Cell Types (2021-2032)
Figure 34. Global Cell Immortalization Revenue-Based Market Share by Doubling Time (2021-2032)
Figure 35. Global Cell Immortalization Revenue-Based Market Share by Application (2021-2032)
Figure 36. North America Cell Immortalization Revenue YoY (US$ Million), 2021-2032
Figure 37. North America Top 5 Players Cell Immortalization Revenue (US$ Million) in 2025
Figure 38. North America Cell Immortalization Revenue (US$ Million) by Application (2021-2032)
Figure 39. US Cell Immortalization Revenue (US$ Million), 2021-2032
Figure 40. Canada Cell Immortalization Revenue (US$ Million), 2021-2032
Figure 41. Mexico Cell Immortalization Revenue (US$ Million), 2021-2032
Figure 42. Europe Cell Immortalization Revenue YoY (US$ Million), 2021-2032
Figure 43. Europe Top 5 Players Cell Immortalization Revenue (US$ Million) in 2025
Figure 44. Europe Cell Immortalization Revenue (US$ Million) by Application (2021-2032)
Figure 45. Germany Cell Immortalization Revenue (US$ Million), 2021-2032
Figure 46. France Cell Immortalization Revenue (US$ Million), 2021-2032
Figure 47. U.K. Cell Immortalization Revenue (US$ Million), 2021-2032
Figure 48. Italy Cell Immortalization Revenue (US$ Million), 2021-2032
Figure 49. Russia Cell Immortalization Revenue (US$ Million), 2021-2032
Figure 50. Asia-Pacific Cell Immortalization Revenue YoY (US$ Million), 2021-2032
Figure 51. Asia-Pacific Top 8 Players Cell Immortalization Revenue (US$ Million) in 2025
Figure 52. Asia-Pacific Cell Immortalization Revenue (US$ Million) by Application (2021-2032)
Figure 53. Indonesia Cell Immortalization Revenue (US$ Million), 2021-2032
Figure 54. Japan Cell Immortalization Revenue (US$ Million), 2021-2032
Figure 55. South Korea Cell Immortalization Revenue (US$ Million), 2021-2032
Figure 56. Australia Cell Immortalization Revenue (US$ Million), 2021-2032
Figure 57. India Cell Immortalization Revenue (US$ Million), 2021-2032
Figure 58. Indonesia Cell Immortalization Revenue (US$ Million), 2021-2032
Figure 59. Vietnam Cell Immortalization Revenue (US$ Million), 2021-2032
Figure 60. Malaysia Cell Immortalization Revenue (US$ Million), 2021-2032
Figure 61. Philippines Cell Immortalization Revenue (US$ Million), 2021-2032
Figure 62. Singapore Cell Immortalization Revenue (US$ Million), 2021-2032
Figure 63. Central and South America Cell Immortalization Revenue YoY (US$ Million), 2021-2032
Figure 64. Central and South America Top 5 Players Cell Immortalization Revenue (US$ Million) in 2025
Figure 65. Central and South America Cell Immortalization Revenue (US$ Million) by Application (2021-2032)
Figure 66. Brazil Cell Immortalization Revenue (US$ Million), 2021-2032
Figure 67. Argentina Cell Immortalization Revenue (US$ Million), 2021-2032
Figure 68. Middle East and Africa Cell Immortalization Revenue YoY (US$ Million), 2021-2032
Figure 69. Middle East and Africa Top 5 Players Cell Immortalization Revenue (US$ Million) in 2025
Figure 70. Middle East and Africa Cell Immortalization Revenue (US$ Million) by Application (2021-2032)
Figure 71. GCC Countries Cell Immortalization Revenue (US$ Million), 2021-2032
Figure 72. Israel Cell Immortalization Revenue (US$ Million), 2021-2032
Figure 73. Egypt Cell Immortalization Revenue (US$ Million), 2021-2032
Figure 74. South Africa Cell Immortalization Revenue (US$ Million), 2021-2032
Figure 75. Cell Immortalization Value Chain Mapping
Figure 76. Channels of Distribution (Direct Vs Distribution)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Cell Immortalization market?
The top companies in the global Cell Immortalization market are Lonza、Thermo Fisher Scientific、JSR.
What is the annual compound growth rate of the global Cell Immortalization market size from 2026 to 2032?
What was the global market size of Cell Immortalization in 2026?
What was the global market size of Cell Immortalization in 2032?
Which region is expected to have the highest market share?
Related Reports
Cell Immortalization - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cell Immortalization was estimated to be worth US$ 3642 million in 2025 and is projected to reach US$ 5461 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-04-30
Pages: 130
USD 3950.00
(Single User License)
Global Cell Immortalization Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cell Immortalization market size was US$ 3642 million in 2025 and is forecast to reach a readjusted size of US$ 5461 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published Date: 2026-04-30
Pages: 139
USD 4250.00
(Single User License)
Global Cell Immortalization Market Research Report 2026
The global Cell Immortalization market was valued at US$ 3642 million in 2025 and is anticipated to reach US$ 5461 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-04-30
Pages: 126
USD 2900.00
(Single User License)
Global Cell Immortalization Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cell Immortalization market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-16
Pages: 107
USD 4250.00
(Single User License)
Global Cell Immortalization Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cell Immortalization market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-16
Pages: 149
USD 4900.00
(Single User License)
Cell Immortalization- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cell Immortalization was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 131
USD 3950.00
(Single User License)
Global Cell Immortalization Market Research Report 2025
The global market for Cell Immortalization was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-07
Pages: 93
USD 2900.00
(Single User License)
Global Cell Immortalization Market Research Report 2024
The global Cell Immortalization market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-02-26
Pages: 90
USD 2900.00
(Single User License)
Cell Immortalization - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Cell Immortalization was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-11
Pages: 127
USD 3950.00
(Single User License)
Cell Immortalization - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Cell Immortalization was estimated to be worth US$ 3642 million in 2025 and is projected to reach US$ 5461 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-04-30
Pages: 130
USD 3950.00 (Single User License)Global Cell Immortalization Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Cell Immortalization market size was US$ 3642 million in 2025 and is forecast to reach a readjusted size of US$ 5461 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published: 2026-04-30
Pages: 139
USD 4250.00 (Single User License)Global Cell Immortalization Market Research Report 2026
The global Cell Immortalization market was valued at US$ 3642 million in 2025 and is anticipated to reach US$ 5461 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-04-30
Pages: 126
USD 2900.00 (Single User License)Global Cell Immortalization Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Cell Immortalization market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-16
Pages: 107
USD 4250.00 (Single User License)Global Cell Immortalization Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Cell Immortalization market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-16
Pages: 149
USD 4900.00 (Single User License)Cell Immortalization- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Cell Immortalization was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 131
USD 3950.00 (Single User License)Global Cell Immortalization Market Research Report 2025
The global market for Cell Immortalization was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-07
Pages: 93
USD 2900.00 (Single User License)Global Cell Immortalization Market Research Report 2024
The global Cell Immortalization market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-02-26
Pages: 90
USD 2900.00 (Single User License)Cell Immortalization - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Cell Immortalization was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-11
Pages: 127
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now